RxDoctor Payments Data

Marina Bota, MD

Psychiatry · Bloomington, INNPI 1164430831

Payments from drug & device makers

$6,049in general payments, 2019–2025

Across 363 payments — averaging $16.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$958
  • Teva Pharmaceuticals USA, Inc.$587
  • Lundbeck LLC$528
  • Alkermes, Inc.$505
  • Johnson & Johnson$426
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$5,93798%
  • Education$1112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,049 in reported general payments places this provider in the 85th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Medicare billing

Part B allowed, 2024
$17,134
Medicare patients
40
Services billed
164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole116$108,383
VraylarCariprazine Hcl61$88,349
AustedoDeutetrabenazine21$81,203
TrintellixVortioxetine Hydrobromide145$78,444
Invega SustennaPaliperidone Palmitate24$64,970
CaplytaLumateperone Tosylate32$55,517
Abilify MaintenaAripiprazole12$33,258
BelsomraSuvorexant26$11,305
ValiumDiazepam12$6,833
Aripiprazole103$5,485
VyvanseLisdexamfetamine Dimesylate14$5,354
Olanzapine144$5,137
Asenapine Maleate32$5,128
Chlorpromazine Hcl21$4,963
Quetiapine Fumarate ErQuetiapine Fumarate30$3,836

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$958$141,641128 claims
AbbVieVraylar$1,077$88,34961 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$186$83,798159 claims
Teva Pharmaceuticals USA, Inc.Austedo$587$81,20321 claims
Johnson & JohnsonInvega Sustenna$426$64,97024 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$312$55,51732 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 514 psychiatry providers in Indiana.

Other psychiatry in Bloomington

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →